ANI Pharmaceuticals reported $65.36M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
AbbVie USD 3.52B 828M Sep/2025
ANI Pharmaceuticals USD 65.36M 5.76M Dec/2025
Aurora Cannabis CAD 15.37M 26.8M Sep/2025
Canopy Growth CAD 16.62M 38.45M Sep/2025
Eli Lilly USD 7.88B 378.1M Sep/2025
Heron Therapeutics USD -3.88M 5.63M Sep/2024
Hikma Pharmaceutical USD 369M 84M Dec/2024
Knight Therapeutics CAD 20.99M 5.48M Sep/2025
Nektar Therapeutics USD -31.81M 70K Sep/2023
Novartis USD 5.84B 235M Sep/2025
Omeros USD -47.96M 7.39M Sep/2023
Perrigo USD 258.8M 37.3M Sep/2025
Sun Pharmaceuticals INR 49.48B 8.52B Dec/2025
Teva Pharmaceutical Industries USD 1.64B 243M Dec/2025